In a 15‑month‑old child with isolated elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and low bilirubin, what is the appropriate evaluation and management?

Evaluation and Management of Isolated Elevated AST/ALT with Low Bilirubin in a 15-Month-Old

In a 15-month-old with isolated elevated AST and ALT and low bilirubin, ultrasound of the abdomen should be the first-line imaging study, while systematically excluding common causes including nonalcoholic fatty liver disease (NAFLD), viral hepatitis (especially CMV), muscle disease, and metabolic disorders—recognizing that this presentation is most often benign and self-limited in young children. 1, 2

Initial Diagnostic Approach

Determine the Pattern and Severity

The hepatocellular pattern (elevated aminotransferases with normal/low bilirubin and normal alkaline phosphatase) indicates hepatocyte injury rather than cholestasis 1. Classify severity:

• Mild: <5× upper limit of normal (ULN)
• Moderate: 5-10× ULN
• Severe: >10× ULN 1

Critical First Step: Rule Out Muscle Disease

Before pursuing extensive liver workup, obtain a creatine kinase (CK) level 3. This is crucial because:

• AST is highly concentrated in muscle cells, not just liver
• Muscular dystrophies (like Duchenne) present with elevated AST/ALT before obvious muscle symptoms appear
• The AST:ALT ratio and absolute CK elevation help distinguish muscle from liver disease
• Missing this diagnosis leads to unnecessary invasive procedures and delayed treatment 3

Essential Laboratory Workup

Obtain the following tests systematically:

Infectious causes (most common in this age group):

• CMV urine antigen or PCR—CMV hepatitis is one of the two most common identifiable causes in young children 4, 5
• Hepatitis A, B, C serologies
• EBV serology if clinically indicated

Metabolic screening (especially if very young or not overweight):

• Fasting glucose and ketones
• Lipid panel
• Consider testing for glycogen storage diseases (GSD type III commonly presents with AST/ALT >500 IU/L, hypoglycemia with ketosis) 6
• Wilson disease screening (ceruloplasmin, 24-hour urine copper) if age-appropriate
• Alpha-1 antitrypsin level and phenotype 1

Autoimmune markers:

• Antinuclear antibody (ANA), anti-smooth muscle antibody
• Immunoglobulin levels
• Note: Low titers of autoantibodies are common in pediatric NAFLD and don't necessarily indicate autoimmune hepatitis 7

Other essential tests:

• Complete blood count (to assess for hemolysis causing indirect hyperbilirubinemia)
• Gamma-glutamyltransferase (GGT)—should be normal in isolated hepatocellular injury
• Albumin and PT/INR—to assess synthetic function

Imaging

Abdominal ultrasound is the appropriate first-line imaging study 1, 2. It can:

• Detect hepatic steatosis (>33% fat content) with 84.8% sensitivity and 93.6% specificity
• Identify structural abnormalities
• Assess for hepatomegaly
• Rule out biliary obstruction (though unlikely given the pattern)

Ultrasound is noninvasive, widely available, and has been validated for screening liver disease in children 1, 2.

Special Considerations for This Age Group

The Benign Natural History

Multiple high-quality studies demonstrate that isolated aminotransferase elevation in healthy young children is predominantly benign 4, 5:

• In one study of 72 children, isolated elevation persisted for 3-36 months (median 11.5 months) and resolved spontaneously 5
• Another study of 87 children showed median duration of 10 months, with values remaining normal for mean 6.4 years after normalization 4
• Even prolonged isolated AST elevation (median 66.6 months) showed benign course with no significant liver disease development 8

Macro-AST Phenomenon

In children with isolated AST elevation (normal ALT), consider macro-AST:

• Macro-AST is AST bound to immunoglobulins, creating a high-molecular-weight complex
• It's a benign laboratory artifact, not true liver disease
• 22% of children with isolated AST elevation test positive for macro-AST 8
• Diagnosed by polyethylene glycol (PEG) precipitation test 9
• More common in older children (mean age 69 months vs. 31 months for borderline) 8

NAFLD in Young Children

While NAFLD is the most common liver disease in developed countries, screening is typically recommended starting at age 9-11 years in overweight/obese children 2, 10. At 15 months:

• NAFLD is uncommon but possible
• Consider if there's obesity or family history
• AST:ALT ratio <1 suggests metabolic disease-related fatty liver (vs. >2 in alcohol-induced, which is irrelevant in this age) 1

Management Algorithm

If Mild Elevation (<5× ULN) with Normal CK:

1. Repeat testing in 1-2 weeks to confirm persistence 1
2. If persistent, complete the workup above
3. If workup negative: Repeat liver enzymes in 1-6 months 10
4. Conservative follow-up is appropriate—most cases resolve spontaneously 4, 5

If Moderate-Severe Elevation (≥5× ULN):

1. More urgent evaluation within 2-5 days 11
2. Complete comprehensive workup immediately
3. Consider referral to pediatric gastroenterology/hepatology
4. Liver biopsy may be considered if:
   • Diagnosis remains unclear after non-invasive testing
   • Concern for progressive disease (GSD, autoimmune hepatitis)
   • However, biopsy showed non-specific findings in most young children and is often unnecessary 5

If Etiology Found:

CMV hepatitis or fatty liver (the two most common identifiable causes):

• CMV: Supportive care, typically self-limited 4
• Fatty liver: Lifestyle modification, nutritional counseling 2

Glycogen storage disease suspected (severe elevation, hypoglycemia, ketosis):

• Urgent metabolic/genetic evaluation
• Controlled fasting study may help differentiate GSD types 6

Key Pitfalls to Avoid

1. Don't pursue extensive liver workup without checking CK first—muscle disease is easily missed 3

2. Don't over-interpret low-titer autoantibodies—they're common in pediatric NAFLD and don't automatically mean autoimmune hepatitis 7

3. Don't rush to liver biopsy—it rarely changes management in young children with isolated elevation and often shows non-specific findings 5

4. Don't forget macro-AST if AST is disproportionately elevated compared to ALT—simple PEG precipitation test avoids unnecessary workup 8, 9

5. Don't assume obesity-related NAFLD at this age—while possible, consider metabolic and infectious causes first 2, 7

Follow-Up Strategy

For idiopathic cases after negative workup:

• Repeat aminotransferases every 1-3 months initially
• If persistently elevated but stable and child remains well, continue monitoring
• Most will normalize within 12 months 4, 5
• Once normalized, document continued normal values for at least 6-12 months
• Reassure family about the generally benign prognosis

Refer to pediatric gastroenterology if:

• Elevation persists >6-12 months without clear cause
• Progressive increase in values
• Development of symptoms (jaundice, hepatomegaly, coagulopathy)
• Concern for specific treatable condition (autoimmune hepatitis, Wilson disease)